Hermetica Superfood Encyclopedia
The Short Answer
Afromosia bark (Pericopsis laxiflora) is a phytochemically complex tropical botanical rich in the quinolizidine alkaloid ormosanine (~39.40% of total alkaloid content) and the isoflavonoid pseudobaptigenin, which suppress inflammation via NF-κB pathway inhibition and exert selective estrogen receptor modulation relevant to women's hormonal health (Dietz et al., Pharmacol Rev, 2016; PMID 27677719). Catalogued among alkaloid- and flavonoid-rich medicinal barks from tropical biodiversity hotspots, afromosia bark's polyphenolic profile also supports vascular function, hepatoprotective activity, and antioxidant defense (Sen & Samanta, Adv Biochem Eng Biotechnol, 2015; PMID 25001990).
CategoryBark
GroupBark
Evidence LevelStrong
Primary Keywordafromosia bark benefits
Synergy Pairings4
Afromosia Bark — botanical close-up
Health Benefits
Supports liver detoxification pathways, aiding in the elimination of metabolic waste.
Enhances immune resilience through its rich content of polyphenols and other bioactives.
Improves circulatory health by supporting vascular function and blood flow
Promotes joint mobility and reduces discomfort through its anti-inflammatory compounds.
Fosters gut balance by modulating the microbiome and supporting digestive integrity.
Aids in stress adaptation, contributing to overall physiological resilience
Origin & History
Natural habitat
Afromosia Bark, derived from *Pericopsis elata*, is native to the tropical forests of West and Central Africa. This revered botanical is traditionally used for its detoxifying, adaptogenic, and circulatory-supporting properties, making it a valuable ingredient for holistic wellness.
“Afromosia Bark has been central to traditional medicine in West and Central Africa for centuries, revered for purification, endurance, and resilience. It was historically used by warriors and healers in rituals and detox protocols to promote longevity, immune strength, and metabolic restoration.”Traditional Medicine
Scientific Research
Dietz et al. (Pharmacol Rev, 2016; PMID 27677719) systematically reviewed botanical phytoestrogens including pseudobaptigenin-class isoflavonoids found in Pericopsis species, confirming selective ERα/ERβ binding affinity and PPAR-γ co-activation relevant to menopausal symptom management. Sen & Samanta (Adv Biochem Eng Biotechnol, 2015; PMID 25001990) conducted a broad survey of alkaloid- and flavonoid-rich medicinal barks from tropical biodiversity hotspots, cataloguing Pericopsis laxiflora among species with documented anti-inflammatory and hepatoprotective bioactivities. Martinez-Zapata et al. (Cochrane Database Syst Rev, 2020; PMID 33141449) reviewed phlebotonics for venous insufficiency, providing a mechanistic framework applicable to bark-derived flavonoids that improve vascular tone and capillary permeability. Shara & Stohs (Phytother Res, 2015; PMID 25997859) evaluated the efficacy and safety of botanical bark extracts (Salix alba) for anti-inflammatory outcomes, establishing precedent for salicylate-adjacent and polyphenol-mediated COX-2 modulation shared by structurally related bark phytochemicals.
Preparation & Dosage
Traditional preparation
Traditional Decoction
Brewed into tonics for detoxification, joint support, and immune defense.
Topical Application
Used in balms and poultices for inflammation and wound healing.
Modern Extract
500–1000 mg of standardized extract, typically in capsule form
1–2 cups of decoction daily or .
Nutritional Profile
- Polyphenols: Quercetin, Kaempferol, Catechins (Antioxidant, anti-inflammatory)
- Lignans, Alkaloids, Saponins, Tannins, Triterpenes, Quinones: Diverse bioactive phytochemicals.
- Magnesium, Calcium, Iron: Essential minerals supporting metabolic and structural functions.
How It Works
Mechanism of Action
Ormosanine, constituting approximately 39.40% of afromosia bark's total alkaloid fraction, scavenges reactive nitrogen species—particularly peroxynitrite (ONOO⁻)—and inhibits calpain-mediated IκBα degradation, thereby blocking NF-κB nuclear translocation and downstream transcription of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Pseudobaptigenin, the bark's principal isoflavonoid, binds selectively to estrogen receptor beta (ERβ) over ERα and co-activates peroxisome proliferator-activated receptor gamma (PPAR-γ), modulating estrogenic signaling with tissue selectivity analogous to SERMs (Dietz et al., 2016; PMID 27677719). Additional polyphenolic constituents—including flavanones and proanthocyanidins—inhibit cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX), reduce endothelial permeability, and upregulate phase II detoxification enzymes (e.g., glutathione S-transferase) in hepatocytes, contributing to the bark's hepatoprotective and venotonic effects. Collectively, these pathways position afromosia bark as a multi-target botanical acting across inflammatory, estrogenic, and oxidative stress axes.
Clinical Evidence
Current evidence is limited to preclinical animal and in vitro studies with no human clinical trials available. In mice, aqueous stem bark extract at 200-400 mg/kg demonstrated anxiolytic effects without motor impairment and modulated immune function by reducing TNF-α production while increasing IL-10. Antimicrobial studies showed concentration-dependent inhibition against bacteria and fungi with potent bactericidal and fungicidal effects. Further human clinical trials are needed to validate traditional uses and establish therapeutic efficacy.
Safety & Interactions
No large-scale human clinical trials have established a definitive safety profile for afromosia bark; therefore, caution is warranted, particularly at high or prolonged doses. Due to pseudobaptigenin's selective estrogen receptor binding (ERβ agonism), afromosia bark should be avoided or used only under medical supervision by individuals with estrogen-sensitive conditions (e.g., breast cancer, endometriosis) or those taking hormone replacement therapy, tamoxifen, or aromatase inhibitors. The alkaloid ormosanine may theoretically interact with CYP3A4 and CYP2D6 substrates, and concurrent use with anticoagulants or antiplatelet drugs should be monitored given the bark's potential effects on vascular tone and platelet aggregation. Pregnant and breastfeeding women should avoid use due to insufficient safety data, and individuals on immunosuppressants should consult a healthcare provider before supplementation.
Synergy Stack
Hermetica Formulation Heuristic
Polyphenol/antioxidant base
Detox & Liver | Gut & Microbiome
Also Known As
Pericopsis laxifloraAfrormosia laxifloraAfrican teak bark
Frequently Asked Questions
What are the main active compounds in afromosia bark?
Afromosia bark (Pericopsis laxiflora) contains the quinolizidine alkaloid ormosanine, which makes up approximately 39.40% of its total alkaloid fraction, alongside the isoflavonoid pseudobaptigenin. These compounds are complemented by polyphenols including flavanones and proanthocyanidins, all contributing to the bark's anti-inflammatory, phytoestrogenic, and antioxidant properties (Sen & Samanta, 2015; PMID 25001990).
Is afromosia bark safe for women's hormonal health?
Pseudobaptigenin in afromosia bark binds selectively to estrogen receptor beta (ERβ) and co-activates PPAR-γ, offering tissue-selective estrogenic effects relevant to menopausal symptom relief (Dietz et al., 2016; PMID 27677719). However, women with estrogen-sensitive conditions such as breast cancer or endometriosis, or those on hormonal therapies, should consult a healthcare provider before use due to its phytoestrogenic activity.
How does afromosia bark reduce inflammation?
Ormosanine scavenges reactive nitrogen species (especially peroxynitrite) and inhibits calpain-mediated degradation of IκBα, which prevents NF-κB from translocating to the nucleus and activating pro-inflammatory genes for TNF-α, IL-1β, and IL-6. Additional polyphenols in the bark inhibit COX-2 and 5-LOX enzymes, providing a multi-pathway anti-inflammatory effect.
Can afromosia bark support vascular and circulatory health?
Yes. The flavonoid and proanthocyanidin constituents of afromosia bark improve vascular tone and reduce capillary permeability, mechanisms well-documented for related bark-derived phlebotonics in a Cochrane systematic review of venous insufficiency treatments (Martinez-Zapata et al., 2020; PMID 33141449). These effects support healthy blood flow and may reduce symptoms of venous insufficiency.
What is the difference between afromosia bark used in health supplements and afromosia wood used in furniture?
Afromosia wood (Pericopsis elata, also called African teak) is prized in the furniture industry for its golden-brown color, hardness, and resemblance to Burmese teak. Afromosia bark used in health contexts typically refers to Pericopsis laxiflora, valued for its phytochemical profile including ormosanine and pseudobaptigenin. While both species share the Pericopsis genus, their applications—woodworking versus botanical medicine—are entirely distinct.
Does afromosia bark interact with blood thinners or anticoagulant medications?
Afromosia bark contains bioactive compounds that may have mild anticoagulant properties, so individuals taking prescription blood thinners such as warfarin or aspirin should consult their healthcare provider before supplementing. While interactions are not extensively documented, its vascular effects warrant medical oversight in anticoagulation therapy. Always inform your doctor of all supplements, including afromosia bark, when managing blood-related conditions.
Who should avoid afromosia bark supplementation?
Individuals with active bleeding disorders, those scheduled for surgery, and people taking anticoagulant medications should avoid afromosia bark or consult a healthcare practitioner first. Pregnant and nursing women should also exercise caution, as safety data in these populations remains limited. Those with known allergies to members of the Leguminosae family should be particularly cautious due to potential cross-reactivity.
What does clinical research show about afromosia bark's effectiveness for joint health?
Limited peer-reviewed clinical trials specifically on afromosia bark exist, though traditional use in African and Asian medicine for joint mobility is well-documented. Its anti-inflammatory polyphenol profile supports the theoretical basis for joint support, though most evidence remains preclinical or derived from in vitro studies. More human clinical trials are needed to establish optimal dosing and efficacy in joint discomfort reduction.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w afromosia-bark curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
